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MitochondrionCardiolipin (CL) is a unique anionic phospholipid speciﬁc to the mitochondria. CL inﬂuences the activity of
electron transport chain enzyme complexes as well as members of the Bcl-2 family. Interactions between Bcl-
2 family members and other pro-apoptotic enzymes have been shown to be crucial for the transduction of
the apoptotic signalling cascades during programmed cell death. Targeting of tBid to the mitochondria, which
is necessary for Bax/Bak oligomerization and cristae remodelling, is dependent on the exposure of CL at
contact sites between the inner and outer mitochondrial membranes. Also, the mobilization of cytochrome c,
another key apoptotic event, is tightly regulated by the oxidative state of cardiolipin. Moreover, CL has been
shown to be essential for translocation and autoprocessing of caspase-8 on the mitochondria after death
receptor stimulation. Deﬁciencies in CL inhibit the formation of tBid and prevent apoptosis by removing an
essential activation platform for the autoprocessing of caspase-8. It is now apparent that CL acts as a crucial
signalling platform from which it orchestrates apoptosis by integrating signals from a variety of death
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1.1. Apoptosis
Programmed cell death, or apoptosis, is a coordinated process
encompassing a series of biochemical events which culminate in the
death of the cell [1–3]. Apoptotic cells are characterized by speciﬁc
morphological changes including chromatin condensation and frag-
mentation and plasma membrane blebbing [2]. In the late stages of
apoptosis the cell becomes fragmented into vesicles called apoptotic
bodies, which contain cytosolic, nuclear and organelle material [2].
The apoptotic bodies are recognized bymacrophages and cleared from
the tissue to avoid inﬂammatory responses. Apoptosis is perpetrated
by the activation of endonucleases and a family of cysteine-dependent
aspartate-speciﬁc proteases, called ‘caspases’. Caspases are activated
by a variety of pathological and cytotoxic stimuli such as death
receptor engagement, cytoskeletal damage, loss of adhesion, DNA
damage, oncogene activation, ER stress, growth factor deprivation,
and oxidative stress amongst others. Mitochondria play a pivotal role
in the execution of apoptotic cell death [4–7]. The transduction of
apoptotic signalling cascades and the execution of cell death requires
permeabilization of the outer mitochondrial membrane (OMM) and
the subsequent release of apoptogenic factors from the mitochondrial
inter-membrane space (IMS) (i.e. cytochrome c, Smac/Diablo, EndoG,
Omi/HtrA2, AIF and cytochrome b) [4,8–11]. The release of cyto-
chrome c leads to the ATP-dependent oligomerization of Apaf-1 and
the formation of the ‘apoptosome’. The apoptosome, a multimeric
complex consisting of cytochrome c, Apaf-1 and ATP, facilitates the
clustering and activation of caspase-9 which, in turn, cleaves and
activates caspase-3 and caspase-7 leading to many of the morpholo-
gical changes associated with apoptosis [4,12].
The permeabilization of the OMM is tightly regulated by the Bcl-2
family of proteins. Bcl-2 family members are evolutionarily conserved
and divided into three subfamilies according to their function and
degree of homology shared within four Bcl-2 homology domains
(BH1-4). In general, the anti-apoptotic Bcl-2 family members (Bcl-2,
Bcl-XL, Bcl-w, Mcl-1 and A1) contain BH domains 1–4 [13] and need to
be neutralized by the other Bcl-2 family members or down regulated
for apoptosis to progress. The pro-apoptotic members can be
subdivided into two groups. The ﬁrst group, often called the multi-
domain pro-apoptotic members, contains BH domains 1–3 and
includes Bax and Bak (and possibly Bok). The second group is made
up of the BH3-only proteins (Bid, Bim, Bad, Bik, Noxa, BMF, bNIP3, HRK
and PUMA) which act as sentinels upstream of the multidomain pro-
apoptotic proteins [14]. The BH3 domain inserts directly into a
hydrophobic groove formed by the BH1-3 domains of multidomain
proteins. There must be a coordinated effort between the different
Bcl-2 family members in order for permeabilization of the OMM to
occur. Despite being constitutively expressed, Bax and/or Bak will
only induce permeabilization of the OMM following apoptotic stimuli,
suggesting that they are inactive in non-apoptotic cells [15,16]. The
speciﬁc mechanism by which the Bcl-2 proteins induce OMM
permeabilization remains controversial (for a recent review see
[14]). Nevertheless, two models have been proposed to explain the
“life/death” switch controlled by the Bcl-2 family of proteins [17]. In
the ﬁrst model, following apoptotic stimuli speciﬁc BH3-only proteins
directly induce Bax or Bak to homo-oligomerize and stably insert into
the OMM, an important prerequisite leading to the permeabilization
of the OMM [14]. In the second model, certain BH3-only proteins may
act to sensitize or “de-repress” Bax and Bak by binding to the anti-
apoptotic (BH1-4) proteins, thereby sequestering and neutralizing the
ability of anti-apoptotic proteins to bind and inhibit the multidomain
pro-apoptotic proteins [14–16]. Cancer cells have developed several
strategies to evade apoptosis by either negatively regulating caspases,
BH3-only and multidomain pro-apoptotic proteins or conversely, by
upregulating anti-apoptotic proteins. Apoptosis also plays a key role inembryonic development, the immune response, viral defence and
normal tissue homeostasis.
1.2. Cardioliopin and apoptosis
Cardiolipin (CL), also known as diphosphatidylglycerol, is an
anionic phospholipid predominantly located in the inner mitochon-
drial membrane (IMM) [18]. However, CL has also been reported to
reside in the OMM and is enriched at contact sites that are formed
between the inner and outer membranes of themitochondria [19–23].
CL is a unique phospholipid which contains four acyl chains, most of
which are highly unsaturated. CL has two negative charges on the
headgroup and is found almost exclusively in mitochondrial mem-
branes. CL associates with numerous proteins of the electron transport
chain, often acting as a crucial component for enzymatic function. CL–
protein interactions also help to orient many receptors, channels and
enzymes on the outer face of the OMM and within the inter-
membrane space (IMS).
CL has been shown to associate with members of the apoptotic
machinery [24]. Speciﬁc interactions between CL and cytochrome c,
Bid and more recently caspase-8 have now been established. It is
becoming apparent that CL is a versatile phospholipid which
participates not only in membrane ﬂuidity and normal electron
transport chain activity, but plays a major role in cell signalling
through CL–protein interactions. This review aims to summarize the
recent advances made in understanding the role of CL as a signal
integrator for multiple proteins during the execution of programmed
cell deathwith an emphasis on three CL-binding proteins: cytochrome
c, Bid and caspase-8. For a comprehensive review on CL metabolism,
function and the role of CL in different pathologies please see [25].
2. Cardiolipin and cytochrome c
Cytochrome c plays a pivotal role in oxidative phophosphorylation
by transferring electrons from Complex III to Complex IV of the
electron transport chain. However, during apoptotic signalling,
cytochrome c is released from the IMS into the cytosol, where it
becomes a potent inducer of the caspase cascade. Within the
mitochondria a substantial portion (∼85%) of the cytochrome c is
trapped within the cristae while the remaining cytochrome c is free in
the IMS [26–29]. In line with this, selective permeabilization of the
OMM with digitonin was not sufﬁcient for complete cytochrome c
release and additionally required cristae remodelling [29–31]. Initial
studies showed that a decrease in total CL levels or oxidation of the
unsaturated acyl chains of CL led to a decrease in membrane-bound
cytochrome c [32–35]. Similarly, the liberation of cytochrome c from
the mitochondria was prevented by antioxidant treatment [36–39] or
by overexpression of redox regulators such as mitochondrial glutar-
edoxin 2 or glutathione peroxidase 4 [34,40,41]. These reports
indicated that a shift in the oxidation state of CL was a coordinated
event involving the production of reactive oxygen species (ROS)
which promoted efﬁcient cytochrome c release. Cytochrome c
contained within the mitochondrial cristae has been shown to
interact with CL in the outer leaﬂet of the IMM [35]. Further studies
have shown that cytochrome c does indeed have a much higher
afﬁnity for CL in comparison to other phospholipids such as
phosphatidylcholine (PC), phosphatidylserine (PS) or phosphatidic
acid (PA) [42]. A very limited portion of CL is available for cytochrome
c binding because of the high percentage of CL found in the inner
leaﬂet of the IMM (∼60%) and the association of CL with many of the
electron transport chain supercomplexes. Studies have approximated
that b15% of the total cytochrome c is bound to CL and b5% of the total
mitochondrial CL is bound to cytochrome c [35,43,44]. Cytochrome c
interacts with CL through two separate binding sites [45]. The ﬁrst
binding site most likely involves weak electrostatic interactions
between the phosphate groups of CL and lysine residues of
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involve hydrogen bonding between one of the polyunsaturated acyl
chains of CL and Asn52 of cytochrome c [43]. It has also been
postulated that the hydrophobic interaction may include the insertion
of one of the acyl chains of CL into a pocket of cytochrome c lined by
hydrophobic residues, such that one of the CL acyl chains protrudes
out of the membrane bilayer to interact with cytochrome c while the
other three acyl chains remain in the membrane [46,47].
The binding of cytochrome c to CL leads to a major negative shift in
the redox potential of cytochrome c which prevents its reduction by
Complex III, superoxide or ascorbate and inhibits its ability to transfer
electrons between Complexes III and IV [48]. In addition to these
effects, Kagan et al. found that CL-bound cytochrome c also acted as a
peroxidase capable of catalyzing H2O2-dependent peroxidation of CL
and that CL oxidationwas essential step in the release of cytochrome c
during apoptosis [44]. CL stimulated the peroxidase activity of
cytochrome c by destabilizing the tertiary structure of cytochrome c
through the hydrophobic interaction(s) [49,50], a process which was
further enhanced by increases in the degree of CL unsaturation
[42,51]. Thus, in the CL-bound state cytochrome c adopts a non-native
conformation which signiﬁcantly alters the heme crevice region [45],
thereby creating a “channel”which facilitates the access of H2O2 to the
heme [49]. Interestingly, the signalling molecules nitric oxide and
carbon monoxide can also associate with the heme of the cytochrome
c–CL complex and may confer a level of apoptotic regulation by
inhibiting the peroxidase activity of cytochrome c [52,53]. CL
oxidation would be dependent on the amount of available H2O2 and
therefore on an increase in the generation and dismutation of
superoxide radicals. The juxtaposition between CL and the electron
transport chain, a major source of ROS, strongly implicates the
enzymes of the supercomplexes as the impetus for ROS-mediated CL
peroxidation [54]. Treatment of mouse embryonic ﬁbroblasts (MEFs)
with actinomycin D caused Bax translocation to the mitochondria and
a subsequent increase in superoxide generation and CL oxidation [55].
In line with this, actinomycin D treated Bax/Bak double knockout
MEFs displayed signiﬁcantly less superoxide and CL oxidation in
comparison to WT MEFs [55]. However, generation of superoxide
radicals by rotenone or succinate was not sufﬁcient for activation of
cytochrome c as a peroxidase or for its release frommitochondria [55].
These cumulative results implied that Bax/Bak insertion and activa-
tion was prerequisite for CL oxidation and cytochrome c release. Rises
in ROS production due to oxidative stress have also been noted as an
early apoptotic event following the activation of the Tumour Necrosis
Factor (TNF) death receptors such as Fas and TNF-R [56,57] and there
has been a suggestion that p66shc, an adaptor protein of the IMSwhich
becomes activated by proapoptotic signalling, can oxidize reduced
cytochrome c and catalyze the reduction of O2 to H2O2 [58]. However,
the steps connecting death receptor activation and activation of p66shc
are speculative, but may involve the dissociation of p66shc from TOM–
TIM import complexes or remodelling of the inner membrane and an
increase of free IMS cytochrome c.
CL remodelling involves the phospholipase-dependent deacylation
of de novo synthesized CL to form monolyso-CL (MLCL) [25], most
likely through a variant of PLA2 [59–62] or MitoPLD [63]. The
reacylation of MLCL has been suggested to be directed by the acyl-
transferase, tafazzin [64]. Tafazzin is able to transfer linoleic acid from
PC to MLCL and is crucial for maintaining the relatively high degree of
unsaturation noted for the acyl chains of CL [65]. An increase in CL
hydrolysis has been shown during the early stages of apoptosis and
would affect the cytochrome c-dependent catalytic oxidation of CL
[43,51,66,67]. Death receptor stimulation of U937, HeLa or Jurkat cells
caused early changes (1 h) in the acyl chain composition of CL,
decreases in CL and increases in MLCL [67,68]. In summation, the
speciﬁc depletion and remodelling of CL, the generation of ROS and
the CL oxygenase capability of cytochrome c are indispensable
components for efﬁcient release of cytochrome c from the IMS.3. Cardiolipin and Bid
After death receptor engagement, the activation of caspase-8
results in the cleavage of Bid (a BH3-only protein) to a truncated form,
tBid [9]. tBid translocates to the OMM and induces the oligomerization
of Bax and/or Bak, which leads to OMM permeabilization. Immuno-
electron microscopy suggested that tBid was targeted in a CL-
dependent manner to the mitochondrial contact sites [69,70]. The
binding of tBid to CL-enriched contacts sites of mitochondria was
shown to minimally require α-helices 4–6 of tBid and was completely
independent of the BH3 domain (α-3 helix) [9]. In addition, tBid
binding to the mitochondria was signiﬁcantly decreased in mitochon-
dria from cells deﬁcient in CL [69]. However, we have noted that
mitochondria isolated from lymphoblastoid cells derived from Barth
syndrome patients, which are devoid of tafazzin activity and therefore
deﬁcient in mature CL, successfully bind tBid [71]. In this case, the
levels of MLCL, which are increased in Barth syndrome lymphoblas-
toid cells, may be sufﬁcient at directing tBid translocation to the OMM
[67,68,72,73]. The interaction of tBid with the OMM may involve the
negatively charged headgroup of CL and basic residues in helices 4–6
[73], but may also involve insertion into the bilayer [74]. However, it
should be noted that other phospholipids, such as PC [75] phospha-
tidylglycerol (PG) and phosphatidylethanolamine (PE), permit tBid
incorporation [76].
The binding of tBid tomitochondria also plays critical roles in other
apoptotic associated processes, such as cristae remodelling [30] and
mitochondrial fragmentation [77]. Cristae remodelling during apop-
tosis, which facilitates the release of cytochrome c, is regulated by the
rhomboid protease PARL and the dynamin-related protein OPA1
[30,31,78]. Mitochondrial PARL actively cleaves the OPA1 protein,
which generates a soluble pool of truncated OPA1 in the IMS. Soluble
OPA1 is crucial for the anti-apoptotic effects of PARL because it
maintains the bottleneck conﬁguration of cristae and the compart-
mentalization of cytochrome c [30,78,79]. The short and long forms of
OPA1 form hetero-oligomers that are disrupted soon after the binding
of tBid to the mitochondria enabling cytochrome c mobilization from
the cristae [30,78,79].
Possibly the best described function of tBid is its ability to induce
Bax/Bak oligomerization, a process which requires the BH3 domain of
tBid. Mitochondrial fractionation studies have detected tBid in
fractions representative of the non-contact site regions of the OMM
[80], which is not unexpected considering tBidmay target Bak in these
areas. 30 nM myristoylated Bid (p7/myrp15) was shown to induce
cytochrome c release much more effectively than 10 μM Bid–BH3
peptide and may reﬂect that an association between tBid and the
OMM, and perhaps more speciﬁcally CL, is needed for concentrating
tBid into certain microdomains (i.e. the contact sites) [15]. Micro-
domains would help in focusing tBid for proper presentation of the
BH3 domain to Bak or Bax [15] and confer prime positioning for
inducing IMM changes like cristae remodelling. In support of this
notion, pre-treatment of mitochondria with the CL-speciﬁc dye, 10-N-
nonyl acridine orange (NAO), caused signiﬁcant inhibition of cristae
remodelling and cytochrome c release after addition of recombinant
tBid, while having minimal effects on Bak oligomerization [29,70,80].
It is important to note that NAO did not prevent tBid incorporation
into the OMM [80]. Furthermore, it has been proposed that
mitochondria may contain lipid microdomains, reminiscent of the
lipid rafts of the plasma membrane [75], which contribute to
apoptosis-associated modiﬁcation of mitochondrial morphology
[81]. The ganglioside GD3, VDAC1 and the ﬁssion protein hFis1
formed a protein complex at lipid microdomains on the OMM of Fas-
activated lymphoblasts into which both tBid and Bax were recruited
[81]. Similarly, during the early steps of staurosporine-induced
apoptosis Bax relocated to lipid microdomains associated with
mitochondrial ﬁssion sites [82]. This complex may be involved in
regulating the activity of mitochondrial ﬁssion-related proteins,
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hexagonal structures in mitochondrial membranes undergoing active
ﬁssion [81]. Moreover, tBid has been suggested to directly alter
membrane curvature [83] and regulate targets involved in cristae
remodelling [29,30]. It seems plausible that targeting and recruitment
of tBid into lipid microdomains on the OMM, most likely through CL
binding, may be necessary for formation of multiprotein complex(es)
which regulate changes in the mitochondrial morphology [81]. Thus,
the BH3 domain of Bid seemed to be important in activating the pro-
apoptotic proteins Bak and Bax, while the Bid–CL interaction played a
functionally distinct role in cristae remodelling and in the formation of
mitochondrial ﬁssion sites. Cristae remodelling was shown to be
essential for full release of cytochrome c and the progression of
apoptosis [29–31]. As mentioned above, cytochrome c release
depended on the dissociation of OPA1 complexes at the cristae
junctions [29–31]. Nevertheless, the question remains as to how
binding of tBid to CL or how the BH3 domain (via Bax/Bak) activates a
mechanism which culminates in OPA1 dissociation.
Bax and Bak are important regulators of the mitochondrial steps of
apoptosis, since cells lacking Bax and Bak were resistant to a diverse
array of apoptotic insults [10]. Activation of these proteins led to their
oligomerization and OMM permeabilization. In vitro studies have
suggested that PLA2-sensitive phospholipids in the OMM were
essential for Bax activation [84]. More recently, studies on the
membrane binding properties of Bax reported that CL was required
for the ﬁrst α-helix of Bax to bind to liposomes which had a
phospholipid composition similar to mitochondrial membrane con-
tact sites [85]. Furthermore, CL was required for Bax insertion and
oligomerization on liposomes, a process which was independent of
the recruitment of tBid [84]. Bax insertion and oligomerization is
thought to occur in a coordinated series of protein–protein and
protein–lipid interactions which culminate in pore formation [86] and
can be completely inhibited by Bcl-XL [87] or Mcl-1 [88]. Liposomal
studies have suggested that Bax initially binds membrane-bound tBid
before inserting into themembrane [86]. The Bax–tBid interactionwas
dependent on the presence of membranes which contained CL. These
initial steps were followed by further recruitment of soluble Bax by
membrane-bound Bax and the formation of pores in the OMM [86].
Endophilin B1/Bax interacting factor 1 (Bif-1) typically modulates
mitochondrial dynamics downstream of Drp1 [89]. However, a new
role for Bif-1 was revealed when it was shown that Bif-1 directly
interacted with Bax through a Bax Binding Motif (BBM) in the
presence of membranes [90]. Bif-1 stimulated Bax oligomerization
and potentiated cytochrome c release [90]. This enhancement was
critically dependent on the presence of CL. Bif-1 may associate with CL
via an N-BAR domain located in the C-terminal region, amotif which is
known to bind to lipid bilayers and cause large scale morphological
rearrangements [91]. The binding of CL to the N-BAR domain of Bif-1
may create CL-enriched microdomains on the OMM, thereby forming
an activation platform upon which Bax can be concentrated and
activated [90]. However, there were reports of Bax activation in the
absence of CL [88,92,93]. In this case, it may not be CL which is
important for the activation of Bax, but rather the modiﬁcation of the
properties of the membrane, which suggests that trans-membrane
migration of CL to the OMM may play a dual role by creating a
preferential lipidic environment while simultaneously establishing
nucleation points for protein signalling cascades and enzymatic
reactions. Alternatively, experiments using CL-deﬁcient proteo-lipo-
somes as an artiﬁcial model for pore formation suggested that an
unknownOMMprotein(s) facilitated tBid-inducedBaxpore formationby
substituting for CL [88].
4. Cardiolipin and caspase-8
There are two separate signalling pathways which lead to
apoptotic cell death. The ﬁrst is the intrinsic pathway, which isactivated from inside the cell by the pro-apoptotic members of the
Bcl-2 protein family. The second is the extrinsic pathway, which is
activated from outside the cell by pro-apoptotic ligands and involves
the clustering of death receptors at the cell surface. Stimulation of the
Fas receptor (CD95/APO-1), a member of the death receptor family,
induces clustering of the receptor and recruits pro-caspase-8 and Fas-
associated death domain (FADD) into a death inducing signalling
complex (DISC) at the plasma membrane [94]. DISC formation
facilitates the clustering, dimerization and autoprocessing of pro-
caspase-8 into an active form which, in turn, directly cleaves the
effector caspases-3 and -7 (type I apoptosis) [94]. In some cell types
(type II apoptosis) the level of caspase-8 activation is too low to
substantially activate caspase-3 directly and requires a mitochondrial-
dependent step to complete the execution of apoptosis. The
mitochondrial step is dependent on the Bcl-2 family of proteins and
can be inhibited by overexpression of anti-apoptotic proteins, such as
Bcl-XL or Bcl-2, or by deﬁciencies in the pro-apoptotic Bcl-2 family
members (Bax, Bak or Bid) [10,95–99].
Pro-caspase-8 was shown to be predominantly localized within
the cytosol, but has also been shown to be loosely associated with the
OMM [100,101]. Recently, it was demonstrated that Fas receptor
activation induced the translocation of active caspase-8 to the
mitochondria, a step that was dependent on the presence of mature
CL in the OMM [71]. Translocation of caspase-8 to the mitochondria
was necessary for efﬁcient caspase-8 processing and activation. The
role for CL in these processes was identiﬁed by using immortalized
lymphoblastoid cells from Barth syndrome patients. Barth syndrome
is a genetic disorder often involving mutations in the tafazzin gene, a
transacylase which catalyzes the transfer of an unsaturated acyl chain
from PC to MLCL. Loss of tafazzin function leads to a decrease in total
CL, a reduction in mature CL and an increase in MLCL. Barth syndrome
lymphoblastoid cells displayed strong resistance to death receptor
activation [71]. However, treatment of mitochondria isolated from
Barth syndrome lymphoblasts with recombinant tBid-induced Bak
oligomerization and cytochrome c release [71]. As stated previously,
the abilities of tBid and Bax to promote OMM permeabilization and
cytochrome c release in Barth syndrome lymphoblastoid cells may
have been due to increased amounts of MLCL. Upon further inspection
it was found that Fas-stimulated Barth syndrome-derived cells had
signiﬁcant inhibition of Bid cleavage suggesting a defect in caspase-8
activation. In addition, isolated mitochondria from tafazzin-knock-
down HeLa cells displayed markedly reduced levels of the processed
forms of caspase-8 and Bid [71]. Therefore mature CL must be critical
for the activation of caspase-8 during Fas-induced apoptosis in
lymphoblastoid and HeLa cells.
The activation of caspases often involves the formation of
triggering complexes and many of these activation platforms have
been described including the DISC for caspase-8 and -10 [102], the
apoptosome for caspase-9 [103], the PIDDosome for caspase-2 [104]
and the inﬂammasome for caspases-1 and -5 [105]. The autoproces-
sing of pro-caspase-8 at the DISC into the fully active caspase-8
involves two sequential cleavage events (Fig. 1). Upon homo-
dimerization, pro-caspase-8 (p55) is ﬁrst cleaved between the two
active subunits p10 and p18 to generate the p43/p10 heterodimer. The
second cleavage occurs in p43 between the death effector domain
(DED) and the p18 subunit to produce the fully active p18/p10 form.
p55 and the ﬁrst cleavage product of caspase-8, p43/p10, associated
with CL-containing membranes and were resistant to an alkaline or
high salt wash, suggesting that caspase-8 partially inserted into the
OMM [71]. This was the ﬁrst proof of caspase-8 integration into the
mitochondrial membrane. The resistance to alkali wash does suggest
that hydrophobic interaction(s) with the unsaturated acyl chains of CL
may contribute to the stability of the interaction. However, caspase-8
was sensitive to trypsin proteolysis suggesting that caspase-8 was still
accessible from the cytosol and only partially inserted into the OMM
[71]. A more detailed biophysical analysis of the CL–caspase-8
Fig. 1. Autoprocessing of caspase-8. After death receptor stimulation pro-caspase-8
(p55) is recruited to the DISC. The DISC facilitates the clustering of caspase-8. Caspase-8
undergoes two sequential cleavage events to create the active form. p55 is ﬁrst cleaved
between the p18 and p10 subunits. However, p18/p10 remains associated in non-
peptidic bonds. The next cleavage separates p18 from the DED (p26) to create the fully
active form of caspase-8 (p18/p10).
Fig. 2. Trans-membrane migration and remodelling of cardiolipin. CL may be relocated
from the IMM to the OMM by PLS3 (in Ca2+-dependent manner) or by lipid transferase
activity of Bid and/or tBid. Alternatively, hexagonal HII phase transition between the
IMM and OMMwould create contact sites which would allow CL to diffuse to the OMM
from the IMM. CL may be hydrolyzed by a variant of PLA2 or MitoPLD to create MLCL in
the OMM. CL may also undergo MitoPLD-dependent hydrolysis to form phosphatidic
acid (PA). MLCL can be reacylated by tafazzin, an acyl-transferase which catalyzes the
transfer of an unsaturated acyl chain from PC to MLCL.
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caspase-8. Additionally, an increased amount of stably inserted p43/
p10 into liposomal membranes containing CL compared to liposomes
lacking CL was noted [71]. Unfortunately, it was impossible to
determine if the increase in p43/p10 had been the product of p55
clustering and processing on the membrane or a higher afﬁnity of
p43/p10 for CL-containing membranes. It will be interesting to
determine if p43/p10 needs to be generated at the DISC before it can
translocate to the mitochondria for further processing to p18/10 or
whether pro-caspase-8 targets CL-enriched domains of the OMM
where it can heterodimerize with other pro-caspase-8 molecules
already present and undergo the cleavage events necessary for
caspase-8 activation. An attractive idea is that CL provides an
activation platform upon which pro-caspase-8 can cluster, oligomer-
ize and process into p43/p10 and p18/p10. Peter et al. demonstrated
that the amount of active caspase-8 generated at the DISC in type II
cells was so small that it was not detected by Western blotting and
suggested that a mitochondrial step was necessary for extrinsic
apoptosis [94]. In support of this notion, p43/p10 was cross linked to
other p43/p10 molecules on the OMM and formed high molecular
weight oligomers [71]. This suggested that caspase-8 processing to its
active form, p18/p10, occurs on the mitochondria through a CL-
dependent clustering of p43/p10. If Bid were also targeted to CL-
enriched regions of the OMM then CL could act as an activation
platform for bringing together both the enzyme (caspase-8) and its
substrate (Bid). It is plausible that caspase-8 binding to the
mitochondria is regulated in a similar manner to other activating
platforms and involves the formation of a ‘mitosome’ triggering
complex.
It remains to be seen if other mitochondrial proteins could target
caspase-8 to the mitochondria. Isolated mitochondria which had been
trypsinized and then incubated with in vitro translated caspase-8
were unable to bind caspase-8, which suggested that a trypsin-
sensitive protein in the OMM was responsible for the association of
caspase-8 with mitochondria [100]. Potential caspase-8 binding
proteins shown to be involved in caspase-8 translocation are BAR
and FLASH [100,106]. Another more recent candidate is the mitochon-
drial membrane protein Cardif (also called IPS-1, MAVS and VISA),
which contains an N-terminal caspase activation and recruitment
domain and a C-terminal death effector domain [107,108]. Cardif was
shown to interact with caspase-8, most likely through FADD, and to be
targeted and inactivated by caspases [109,110].
The way in which caspase-8 associates with CL has not been
determined, but seems to be dependent upon both the maturity
(unsaturation) and total amount of CL. Unlike tBid, which can
associate with either MLCL or CL, p43/p10 speciﬁcally interactedwithmature CL. Our experiments did not determinewhether caspase-
8was bound to CL or to peroxi-CL, though the liposomal studies would
suggest peroxidation is not necessary. It would be interesting to see if
caspase-8 insertion into the OMM is dependent upon or enhanced by
peroxidation of CL. Peroxi-CL would then act to free cytochrome c
from the IMM and as a signal to promote caspase-8 (and Bid)
association with the OMM. However, gas chromatography, NAO
staining and electron microscopy studies on NGF-deprived neurons
suggested that the major ROS-induced CL peroxidation may be
downstream of cytochrome c release and the activation of caspases,
since it could be blocked by caspase inhibition [111]. NGF-deprivation
also caused loss of mitochondrial mass in a oxidation-dependent
manner, most likely by autophagocytosis of damaged mitochondria,
suggesting that ROS-associated damage of CL leads to mitochondrial
destruction via an autophagic pathway [111].
Similar to the multiple roles played by Bid/tBid (i.e. lipid transfer,
membrane modiﬁcations, cristae remodelling, mitochondrial ﬁssion/
fusion) perhaps there are other roles for caspase-8 in altering
membrane structure upon CL binding or other substrates which
play, as of yet, unidentiﬁed roles in the processes involved in the
execution of type II apoptosis.
5. How does CL translocate to the outer mitochondrial
membrane?
5.1. Contact sites
It has been over four decades since contact sites between the inner
and outer mitochondrial membranes were ﬁrst described [112]. These
sites have been speculated to facilitate the transport of proteins and
small molecules (i.e. metabolite and ions) between the cytosol and the
inner mitochondrial matrix [113]. Further examination of the content
of contact sites revealed that CL (25%) and PE (25%) constitute the two
major phospholipids presentwithin the contact site [22,114]. Although
not yet described in vivo, in the presence of Ca2+ the IMM and OMM
are predicted to form a non-bilayer hexagonal HII structure at the
contact sites given the high percentage of CL and PE [24,115–118]. CL
and PE are non-lamellar lipids with a high propensity for negative
membrane curvature which can spontaneously form inverted hex-
agonal lipid phases and cause signiﬁcant stress in the lipid packing of
the acyl chain region of the bilayer. The fusion of the IMM and OMM
would allow CL to redistribute to the surface of the mitochondria and
permit interactions with cytosolic proteins (Fig. 2).
2027Z.T. Schug, E. Gottlieb / Biochimica et Biophysica Acta 1788 (2009) 2022–20315.2. Protein-mediated contact site formation and stabilization
The physiological presence of contact sites has been under debate
for many years. Nevertheless, it seems that the number and stability of
contact sites may be strongly inﬂuenced by a number of different
proteins, although the exact mechanismwhich triggers the formation
of the contact site is still unknown. A role for mitochondrial creatine
kinase (MtCK) in the formation and stabilization of contact sites has
recently been suggested [119,120]. Epand et al. described an interac-
tion between the octameric ubiquitous form of mitochondrial creatine
kinase (uMtCK) and CL which potently induced the lipid phase
separation of CL into discrete domains in vitro [121]. Transgenic mice
expressing the uMtCK displayed a 3-fold increase in the number of
contact sites compared toWTcontrol mice [122]. Furthermore, within
the contact sites uMtCK may bind to CL on the IMM and VDAC on the
OMM to form a bridge across the double membrane of the
mitochondria which stabilizes the CL-enriched contact site [121].
Interestingly, the same study showed that both cytochrome c and tBid
were capable of producing CL clustering, although to a lesser extent
[121].
5.3. CL trans-membrane migration
Recently, there have been investigations into the trans-bilayer
movement and intracellular distribution of CL. In cells undergoing
staurosporine-induced apoptosis the CL content in the OMM was
signiﬁcantly increased [44,123] while the CL (mol%) distribution of the
outer leaﬂet to the inner leaﬂet of the IMMwent from 40:60 to 70:30,
respectively [44]. The intra-mitochondrial movements of CL occur
very early during apoptosis, well before changes in mitochondrial
membrane potential or nuclear condensation and fragmentation, but
after the production of ROS [124]. These changes in CL distribution
during apoptosis could be directed by Bid. There is evidence that Bid,
and to a greater extent tBid, possesses lipid transfer activity (Fig. 2)
[67,76,125]. Bid may act to translocate CL to the OMM surface which
would then promote further caspase-8 binding and Bid binding, as
well as disruption of the CL–cytochrome c interaction. However, the
exact physiological function of Bid and tBid lipid transfer activity is not
well understood leading others to suggest that tBid may act by
augmenting a Bax-dependent CL redistribution between the mito-
chondrial membranes. Studies using liposomes suggested that the
rate at which the translocation of CL to the OMM occurs was enhanced
by oligomeric Bax and that liposomes containing CL were more
susceptible to leakage in the presence of Bax than those containing the
CL precursor PG [16,126]. Furthermore, Bid association with the
mitochondriawould have to occur prior to caspase-8 cleavage of Bid to
tBid and after death receptor activation. There are reports of
recombinant Bid binding to liposomes containing CL or MLCL
[72,76]. In mouse liver, Fas-induced apoptosis caused an early increase
in mitochondrial-bound Bid which was concomitant with the
appearance tBid and cytochrome c release [72]. It is important to
note that Bid was detectable in untreated mitochondria isolated by
subcellular fractionation frommouse livers [72]. There are also reports
of Bid inserting speciﬁc lysolipids into the mitochondrial membrane,
similar to the lipid transfer activity of Bid described above for CL
[67,76,125], thereby priming mitochondria for the release of apopto-
genic factors [125,127]. Similarly, incubation of mouse liver mitochon-
dria with tBid-induced PLA2 activation and the trans-membrane
migration of CL and its hydrolysis products [125]. Overall, the tBid-
induced translocation of CL between all four leaﬂets has many
consequences i) increased cytochrome c–CL interactions, ii) enhanced
peroxidation of CL, iii) enhanced release of cytochrome c, iv)
mitochondrial bioenergetic disruption and v) large membrane
perturbing effects such as the formation of CL-enrichedmicrodomains,
cristae remodelling and the accumulation of lyso-phospholipids
[125,128].5.4. Ca2+ and CL
Increases in the [Ca2+]m occur after death receptor stimulation and
stimulate multiple mitochondrial enzymes, including pyruvate dehy-
drogenase, α-ketoglutarate dehydrogenase and isocitrate dehydro-
genase whose increased activity results in higher ROS production
unless accompanied by a concomitant increase in ADP. Ca2+-induced
oxidative stress generates superoxide radicals which are promptly
dismutated to H2O2. As discussed above, the formation of H2O2
promotes the cytochrome c-dependent peroxidation of CL. Peroxi-CL
has a different molecular conformation and altered packing char-
acteristics which can promote formation of a non-bilayer hexagonal
structure and exposure of CL to the cytosolic surface of the
mitochondria [116].
Phospholipid translocators are highly regulated enzymeswhich play
vital roles in membrane biogenesis and in the maintenance of
membrane asymmetry [129]. Phospholipid scramblases (PLS) are a
small family of phospholipid translocators which contain a single pass
trans-membrane domain and an EF-hand-like Ca2+-binding motif. PLS
induce non-speciﬁc bi-directional movement of phospholipids across
themembrane during cell activation in response to rises in [Ca2+]c. PLS3
is localized to the mitochondria and has been shown to translocate CL
from the IMM to the OMM during apoptosis induced by UV-irradiation
[130,131] (Fig. 2). Overexpressing PLS3 in HeLa cells led to an increase in
ROS production by an unknown mechanism [130,131]. These processes
maybeenhancedby the lipid transferactivityof tBid. Furthermore, it has
been shown that stimulation of the Fas receptor in Jurkat cells led to the
activation of PLCγ1,which in turn generated IP3 receptor-mediated Ca2+
release [132]. IP3-mediatedCa2+ release caused a rise in [Ca2+]mdue to a
local Ca2+ transfer between IP3 receptors and mitochondrial Ca2+
uptake sites [133,134] Rises of [Ca2+]m during the early stages of type II
extrinsic apoptosis may trigger the activation of PLS3 which
translocates CL to the OMM where it would have the opportunity to
interact with caspase-8 and Bid. Indeed, PLS3 overexpression has been
shown to enhance the level of TRAIL-induced caspase-8 processing in
Jurkat cells [135].
Ca2+ has long been known to play a crucial role in apoptosis
[136,137]. Ca2+ has the ability to bind to CL thereby neutralizing the
negatively charged headgroup of CL. The Ca2+–CL interaction has been
suggested to be an early and fundamental step by which Ca2+ triggers
OMM permeabilization. The effects of the Ca2+–CL interaction include
the induction of lateral phase separation and formation of CL-enriched
domains, protein aggregation, increased membrane permeability, and
promotion of lipid peroxidation by optimizing the conﬁguration of
proteins and lipids for attack by ROS [117]. CL is associated with
numerous proteins within the mitochondria, many of which are
associated with the electron transport chain supercomplexes [35,138–
140]. The formation of Ca2+-induced CL-enriched domains would be
expected not only to affect the lipid microenvironment, but also to
inﬂuence the lateral motion, conformation and function of membrane
proteins of the electron transport chain supercomplexes. Together
these data would suggest that an early and initial rise in [Ca2+]m after
induction of apoptosis could be important for the distribution of CL
into discreet functional domains thereby concentrating particular CL-
binding enzymes and proteins and thus behaving as a signal
integrator. Moreover, it is plausible that the binding of tBid, and
potentially caspase-8, further induces lateral phase separation in a
feed-forward mechanism in order to create a signalling platform from
which OMM permeabilization could manifest.
After death receptor engagement activated caspase-8 cleaves Bid
to promote mitochondrial release of cytochrome c, Smac/Diablo
[97,141], the death domain kinase RIP to prevent the activation of NF-
κB survival responses [142] and the cytolinker plectin for disassembly
of microﬁlaments [101]. Recently, knockdown of Apaf-1 or cyto-
chrome c did not completely prevent Fas-induced cell death in HeLa
cells [11]. In this scenario, Fas receptor activation triggered intra-
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dent on caspase-8 (and Bid) activity and suggested that caspase-8
may activate an unidentiﬁed intra-mitochondrial protease. Once
cleaved cytochrome b translocated to the cytosol and activated a
caspase-dependent (apoptosome-independent) cell death. Caspase-8
also cleaves BAP31, an integral protein of the ER membrane [143],
which generates a membrane-bound fragment, called p20, that is
capable of inducing apoptosis when expressed ectopically [144,145]. A
caspase-resistant mutant of BAP31 inhibited Fas-mediated apoptosis
by preventing mitochondrial remodelling and the release of cyto-
chrome c despite normal caspase-8 activation [145]. The BAP31
cleavage product, p20, stimulated a direct release of ER Ca2+ into the
mitochondria which sensitized the mitochondria to OMM permeabi-
lization [146]. The uptake of Ca2+ by mitochondria also triggered the
recruitment of Drp1, a key protein involved in the induction of
mitochondrial ﬁssion, to the OMM [147]. It should be noted that a
mechanism was recently proposed which described mitochondrial
fragmentation as an occurrence that accompanied OMM permeabili-
zation (Bax/Bak activation) and that cytochrome c release and
mitochondrial ﬁssion are two separable events [148]. Overexpression
of the BH3-only ER-membrane protein BIK was also capable of
inducing an early and robust release of Ca2+ from the ER stores in a
Bax/Bak-dependent manner as evidenced by the ability of Bik to
release Ca2+ from ER stores in transformed kidney epithelial cells
derived from wild-type, but not from Bax/Bak double knockout mice
[149]. Furthermore, Bik-mediated cell death was dependent on Drp1
and caspase activation [149]. Could Bik- or p20-mediated rises in
[Ca2+]m lead to the activation of the Ca2+-dependent PLS3, the
generation of ROS through enhancement of matrix dehydrogenase
activity, disruption of CL–cytochrome c interactions, lateral phase
transitions and promotion of bilayer to hexagonal HII phase transi-
tion? In summary, these above ﬁndings support the idea of a “two hit”
model in which the transfer of an ER Ca2+ signal to the mitochondria
and a parallel BH3-dependent hit collaborate to promote the
mitochondrial phase of apoptosis [146,150,151]. All of these factors
together suggest that major perturbations in the CL distribution,
metabolism and redox status play major roles in apoptosis. However,
at the moment these connections remain largely speculative and only
additional research will explain how changes in the location and state
of CL affect the different steps of programmed cell death.
6. Conclusions
The identiﬁcation of the CL–caspase-8 interaction has further
emphasized the critical importance of CL distribution within the
mitochondrial membranes during apoptosis. CL seems to act as a
platform upon which multiple apoptotic signals converge to coordi-
nate programmed cell death. There is a need to identify if the amount
of CL found at the contact sites is sufﬁcient to support the dynamic
processes involved in mitochondria remodelling, ﬁssion and OMM
permeabilization or if there is a regulated mechanism needed which
causes CL migration from the inner leaﬂet of the IMM to the outer
leaﬂet of the OMM. Possible candidates for CL alterations include Bid
lipid transfer activity, acyl chain remodelling, PLA2 activation and
MLCL formation, PLS3 activation, Ca2+-induced hexagonal HII phase
non-lamellar membrane formation and ROS production. Also, at the
present it is not known if changes in mitochondria are needed before
translocation of caspase-8 and/or Bid.
7. Perspectives
Biomedical research on the roles of biological membranes has
revealed them as signalling and trafﬁcking platforms for many
fundamental processes involved in cellular growth, maintenance,
metabolism, and homeostasis. Moreover, genetic abnormalities in
lipid metabolism are often associated with diseases such as cancer,arthritis, diabetes and in the case of CL, Barth syndrome. Therefore,
there is a need to comprehensively understand protein–lipid interac-
tions for the identiﬁcation of practical targets for drug development.
Protein–protein interactions have dominated the ﬁeld for many years,
but more recently the signiﬁcance of protein–lipid interactions has
received more attention. The lipid microenvironment has long been
known to affect receptors, ion channels and scaffolding complexes and
more recently membrane recruitment of peripheral proteins. It seems
that the spatial and temporal interactions between caspases and Bcl-2
family members with mitochondrial CL are vital to the progression of
apoptosis. However, the mechanisms by which the pro- and anti-
apoptotic protein family are recruited to and interact with the
mitochondrial membranes remain poorly characterized. Nevertheless,
there is now an unquestionable need to exploit lipid-binding proteins
in drug development targeted at cellular membranes.Acknowledgements
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